NCT06064058 is a NA clinical trial of Ghazwan program in Back Pain Lower Back Chronic, sponsored by University of Baghdad.

Who is sponsoring NCT06064058?

NCT06064058 is sponsored by University of Baghdad.

What drugs are being tested in NCT06064058?

Interventions in NCT06064058: Ghazwan program, Standard management.

What condition does NCT06064058 study?

NCT06064058 studies Back Pain Lower Back Chronic, Back Pain, Pre Diabetes, Diabetes, Back Pain, Low.

Is NCT06064058 still recruiting?

NCT06064058 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT06064058

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Completed NA Last updated 5 October 2023

What this trial tests

NA trial testing Ghazwan program in Back Pain Lower Back Chronic in 90 participants. Completed in 1 September 2023.

Timeline

30 January 2023

Primary endpoint
30 August 2023

1 September 2023

Quick facts

Lead sponsor	University of Baghdad
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	90
Start date	30 January 2023
Primary completion	30 August 2023
Estimated completion	1 September 2023
Sites	1 location across Iraq

Drugs / interventions tested

Ghazwan program
Standard management — full drug profile →

Conditions studied

Back Pain Lower Back Chronic — all drugs for Back Pain Lower Back Chronic →
Back Pain — all drugs for Back Pain →
Pre Diabetes — all drugs for Pre Diabetes →
Diabetes — all drugs for Diabetes →

Sponsor

University of Baghdad

Who can join

20 and older, any sex, with Back Pain Lower Back Chronic or Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels through lifestyle interventions and, along with the correction of vitamin D and magnesium, can alleviate nonspecific back pain in prediabetic patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessing the Effects of HbA1c Reduction on Alleviating Chronic Nonspecific Low Back Pain in Prediabetic Non-obese Patients: A Non-Randomized Controlled Trial.
Hasan GA, Al-Obaidi AD, Hashim HT, Najah Al-Obaidi M, et al · · 2024 · PMID 39559515 · DOI 10.1177/11795514241300995

Verify or expand the search:

Other recruiting trials for Back Pain Lower Back Chronic

Currently open trials in the same condition.

NCT07334288 — Retrolaminar Analgesia for LuMbar Surgery · NA · recruiting
NCT06825390 — AuriculoTherapy NeuroImaging · NA · recruiting
NCT06476392 — Melatonin fOr CHronic bAck Pain (The MOCHA Trial) · Phase 3 · active not recruiting
NCT05851196 — The Forgotten Role of Back Muscle Characteristics to Tailor Exercise Therapy for Recurrent Non-specific Low Back Pain · recruiting
NCT05704751 — EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients · recruiting

Other University of Baghdad trials

Trials by the same sponsor.

NCT07417839 — (Effect of Toy Nebulizer Versus Distraction Cards on Children's Fear and Parental Satisfaction During Nebulization Thera · NA · not yet recruiting
NCT07456657 — Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis · NA · not yet recruiting
NCT07460089 — Premature Infant Oral Motor Intervention vs. Pacifier for Oral Feeding Transition in Preterm Infants · NA · not yet recruiting
NCT07350343 — The Predictability of Directly Printed Versus Thermoformed Clear Aligners · NA · enrolling by invitation
NCT07362160 — Clear Orthodontic Expander Versus Hyrax · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06064058 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Baghdad
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06064058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing